1 day ago
Varun Sharma, founder and CEO of NEUVIOR, reflects on the necessitates of the recently forged India-UK pharma trade deal.
The India UK Comprehensive Economic and Trade Agreement became operational on 15 July. That is good news for businesses in both countries. It is also the moment to stop treating tariff reduction as a synonym for market access, especially in pharmaceuticals, medical technology and digital health.
Medicines and devices do not move from factory to patient through one gate. They move through at least five. A product must qualify for the tariff preference under the rules of origin. It must have the right approval in the destination market. Its manufacturing and quality evidence must withstand inspection. It must meet the terms of any public procurement. Its people, systems and data must be able to operate lawfully across borders.
The agreement changes some of these gates. It does not collapse them.
The Indian schedule places 198 of 226 pharmaceutical tariff lines in immediate staging, four already at zero, with the rest phased over five or ten years. Medical technology receives a more mixed pattern of phased elimination and partial reduction. These preferences matter, but only for products that satisfy the product specific origin rule.
#trade #market #technology #move
The India UK Comprehensive Economic and Trade Agreement became operational on 15 July. That is good news for businesses in both countries. It is also the moment to stop treating tariff reduction as a synonym for market access, especially in pharmaceuticals, medical technology and digital health.
Medicines and devices do not move from factory to patient through one gate. They move through at least five. A product must qualify for the tariff preference under the rules of origin. It must have the right approval in the destination market. Its manufacturing and quality evidence must withstand inspection. It must meet the terms of any public procurement. Its people, systems and data must be able to operate lawfully across borders.
The agreement changes some of these gates. It does not collapse them.
The Indian schedule places 198 of 226 pharmaceutical tariff lines in immediate staging, four already at zero, with the rest phased over five or ten years. Medical technology receives a more mixed pattern of phased elimination and partial reduction. These preferences matter, but only for products that satisfy the product specific origin rule.
#trade #market #technology #move
5 days ago
Investors were eagerly anticipating Alphabet's (NASDAQ: GOOG) (NASDAQ: GOOGL) second-quarter earnings report on Wednesday, and the numbers did not disappoint.
Alphabet nearly doubled revenue in the key cloud segment, with Google Cloud revenue up 82% to $24.8 billion. Even more impressive was operating income in the cloud segment, which more than tripled to $8.8 billion, thanks to the boom in AI infrastructure spending.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Alphabet's overall numbers were strong as well, as revenue jumped 24% to $119.8 billion, well ahead of the consensus at $117 billion.
Operating margin also expanded from 32% to 34%, translating into $40.8 billion in operating income. Despite those strong results, Alphabet stock was down after hours, losing as much as 5% before clawing back some of those losses.
#billion
Alphabet nearly doubled revenue in the key cloud segment, with Google Cloud revenue up 82% to $24.8 billion. Even more impressive was operating income in the cloud segment, which more than tripled to $8.8 billion, thanks to the boom in AI infrastructure spending.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Alphabet's overall numbers were strong as well, as revenue jumped 24% to $119.8 billion, well ahead of the consensus at $117 billion.
Operating margin also expanded from 32% to 34%, translating into $40.8 billion in operating income. Despite those strong results, Alphabet stock was down after hours, losing as much as 5% before clawing back some of those losses.
#billion
6 days ago
This article was originally published on ETFTrends.com.
Bitcoin, the largest digital currency by market capitalization, is showing signs. It surpassed the psychologically important $65,000 level and is higher by nearly 3% for the week ending July 21.
It remains to be seen if months of cryptocurrency frustration are nearing an end. The same is true regarding a bitcoin bottom. However, with the CLARITY Act close to passing and bullish price action of late, crypto investors may have credible reasons to get back in the game. Thanks to the NEOS Bitcoin High Income ETF (BTCI), market participants can earn compensation while waiting for the bitcoin dust to settle.
The $1.12 billion BTCI turns two years old in October and has rapidly become royalty in the bitcoin income ETF ***** e. The actively managed BTCI writes or sells options on a pair of well-known spot bitcoin ETFs, ensuring a solid liquidity profile. It's a smart income move, as highlighted by a 30-day SEC yield 2.13% — a percentage previously unthinkable with crypto ETFs.
BTCI's status as an income-generating bitcoin avenue is potentially attractive at a time when some market participants are apprehensive about what comes next for the dominant digital currency.
#Bitcoin #btci #Crypto
Bitcoin, the largest digital currency by market capitalization, is showing signs. It surpassed the psychologically important $65,000 level and is higher by nearly 3% for the week ending July 21.
It remains to be seen if months of cryptocurrency frustration are nearing an end. The same is true regarding a bitcoin bottom. However, with the CLARITY Act close to passing and bullish price action of late, crypto investors may have credible reasons to get back in the game. Thanks to the NEOS Bitcoin High Income ETF (BTCI), market participants can earn compensation while waiting for the bitcoin dust to settle.
The $1.12 billion BTCI turns two years old in October and has rapidly become royalty in the bitcoin income ETF ***** e. The actively managed BTCI writes or sells options on a pair of well-known spot bitcoin ETFs, ensuring a solid liquidity profile. It's a smart income move, as highlighted by a 30-day SEC yield 2.13% — a percentage previously unthinkable with crypto ETFs.
BTCI's status as an income-generating bitcoin avenue is potentially attractive at a time when some market participants are apprehensive about what comes next for the dominant digital currency.
#Bitcoin #btci #Crypto
8 days ago
General Motors raised its full-year profit forecast by another $500 million after beating second-quarter earnings estimates, powered by stronger margins on its largest vehicles and lower tariff costs. Bloomberg's David Welch joins to discuss.
#year
#year
15 days ago
As expected, the US president upped his War on Iran over the weekend with headlines telling us of increased fighting over the Strait of Hormuz.
The continued rally in the price of Energies has seen the Fed fund forward curve shift, now indicating a possible rate hike at the conclusion of the September 2026 meeting.
Crude Oil Prices Surge as US Reinstates Blockade of Iran
Despite Multiple, Positive Attributes, Fervo Energy Stock Looks Very Risky for Now
Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market ****** ysis you won't find anywhere else.
The continued rally in the price of Energies has seen the Fed fund forward curve shift, now indicating a possible rate hike at the conclusion of the September 2026 meeting.
Crude Oil Prices Surge as US Reinstates Blockade of Iran
Despite Multiple, Positive Attributes, Fervo Energy Stock Looks Very Risky for Now
Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market ****** ysis you won't find anywhere else.
16 days ago
Coursera (COUR) stock was listed in March 2021 and the stock briefly traded at all-times highs above $50. With the Covid-19 pandemic necessitating shift to online classes, Coursera was among the beneficiaries.
However, the positive momentum in the stock was short-lived and the downtrend has sustained. In the last 52-weeks, COUR stock has declined 32.2% with negative sentiments on the back of growth concerns.
'Shark Tank' Star Kevin O'Leary 'Can't Stand It' When Young People Spend $28 on Lunch But Only Make $70k — 'I Mean, That's Just Stupid'
Broadcom Lands $30 Billion Chip Deal With Apple. Why It's a Win-Win for AAPL and AVGO.
Intel Future Price Hikes Send Huge Demand Signal to Wall Street
However, the positive momentum in the stock was short-lived and the downtrend has sustained. In the last 52-weeks, COUR stock has declined 32.2% with negative sentiments on the back of growth concerns.
'Shark Tank' Star Kevin O'Leary 'Can't Stand It' When Young People Spend $28 on Lunch But Only Make $70k — 'I Mean, That's Just Stupid'
Broadcom Lands $30 Billion Chip Deal With Apple. Why It's a Win-Win for AAPL and AVGO.
Intel Future Price Hikes Send Huge Demand Signal to Wall Street
